79495-87-7

Usage

InChI:InChI=1/C21H32O4/c1-6-19-14(2)9-7-8-10-18(22)16(4)13-17(5)21(24)15(3)11-12-20(23)25-19/h7-12,14-17,19,21,24H,6,13H2,1-5H3/b9-7-,10-8-,12-11+/t14-,15-,16+,17-,19+,21-/m0/s1

Upstream product

• 94339-75-0 (E)-(S)-4-((3S,5R)-3,5-Dimethyl-6-oxo-tetrahydro-pyran-2-yl)-pent-2-enoic acid methyl ester 
• 94339-71-6 [(2S,3R)-3-((1R,3S)-4-Benzyloxymethoxy-1,3-dimethyl-butyl)-2-methyl-oxiranyl]-methanol 
• 94339-82-9 (E)-(4S,5R)-4-Methyl-5-(tetrahydro-pyran-2-yloxy)-hept-2-enoic acid methyl ester 
• 69536-53-4 (3S,5R)-6-((R)-2-Hydroxy-1-methyl-ethyl)-3,5-dimethyl-tetrahydro-pyran-2-one 
• 94424-88-1 (2R,3R)-3-(ethyloxiran-2-yl)methanol 
• 94339-85-2 (2E,10E,12E)-(4S,5S,6S,8R,14S,15R)-5-(tert-Butyl-dimethyl-silanyloxy)-4,6,8,14-tetramethyl-9-oxo-15-(tetrahydro-pyran-2-yloxy)-heptadeca-2,10,12-trienoic acid methyl ester 
• 1027197-93-8 (E)-(4S,5S,6S,8R)-5-(tert-Butyl-dimethyl-silanyloxy)-10-(dimethoxy-phosphoryl)-4,6,8-trimethyl-9-oxo-dec-2-enoic acid methyl ester 
• 94339-88-5 (3E,11E,13E)-(5S,6S,7S,9R,15S,16R)-6-(tert-Butyl-dimethyl-silanyloxy)-16-ethyl-10-hydroxy-5,7,9,15-tetramethyl-oxacyclohexadeca-3,11,13-trien-2-one 
• 94339-86-3 (2E,10E,12E)-(4S,5S,6S,8R,14S,15R)-5-(tert-Butyl-dimethyl-silanyloxy)-9,15-dihydroxy-4,6,8,14-tetramethyl-heptadeca-2,10,12-trienoic acid methyl ester 
• 94339-87-4 (2E,10E,12E)-(4S,5S,6S,8R,14S,15R)-5-(tert-Butyl-dimethyl-silanyloxy)-9,15-dihydroxy-4,6,8,14-tetramethyl-heptadeca-2,10,12-trienoic acid 
• 94339-76-1 C₂₅H₅₀O₅Si₂ 
• 94339-73-8 Acetic acid (1S,2S,4R)-1-((S)-2-acetoxy-1-methyl-ethyl)-5-benzyloxymethoxy-2,4-dimethyl-pentyl ester 
• 94339-78-3 (E)-(4S,5S,6S,8R)-5-(tert-Butyl-dimethyl-silanyloxy)-8-chlorocarbonyl-4,6-dimethyl-non-2-enoic acid methyl ester 
• 94339-77-2 (E)-(4S,5S,6S,8R)-5-(tert-Butyl-dimethyl-silanyloxy)-4,6,8-trimethyl-non-2-enedioic acid 1-methyl ester 

Downstream Products

• 77704-61-1 Myconolide IV 

Relevant academic research and scientific papers

TOTAL SYNTHESIS OF PROTOMYCINOLIDE IV

A 16-membered macrolide antibiotic, protomycinolide IV, was synthesized from two fragments to which the chirality was introduced by asymmetric epoxidation of the appropriately chosen allylic alcohols.A new synthesis of the Prelog-Djerassi lactonic acid from one of the intermediates of the synthesis was also carried out.